logo
Domino's Pizza Generates Strong Q2 Free Cash Flow - DPZ Stock Looks Cheap

Domino's Pizza Generates Strong Q2 Free Cash Flow - DPZ Stock Looks Cheap

Yahoo21-07-2025
Domino's Pizza (DPZ) announced strong Q2 results this morning, showing free cash flow FCF up over 31% YoY with a high FCF margin. DPZ stock is undervalued here, worth over 21% more, or $566.00 per share. Shorting OTM puts is a way to buy in cheaply.
DPZ is lower at $464.76 in midday trading. That is well off its high point of $497.52 on May 19.
More News from Barchart
Option Volatility And Earnings Report For July 21 - 25
How to Make a 3.0% One-Month Yield By Shorting UBER Puts
What Gamma Exposure is Saying About Alphabet Stock Ahead of Earnings
Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now!
It presents a unique buy-in opportunity for value investors. This article will show that, based on its FCF margin history and a 3.9% FCF yield metric, it could be worth 21% more at $566.45. And it could be worth much more based on its historic dividend yield metrics.
Domino's Pizza Strong Results
Monday morning, July 21, Domino's Pizza reported that its revenue rose +4.3% YoY and U.S. same-store sales growth was up 3.4% (int'l rose +2.4%).
More importantly, Domino's showed strong free cash flow (FCF) performance. It generated $331.7 million in FCF over the past 2 quarters, up 43.9% YoY. Moreover, in Q2 it generated $167.3 million in FCF, up +1.81% from Q2, according to Stock Analysis.
This is important since it shows that Domino's has now generated two quarters with over 14% FCF margins (i.e., FCF/revenue). In Q2, its FCF margin was 14.61% and in Q1, it made a 14.78% FCF margin, according to Stock Analysis. In the past 2 quarters, that average was 14.7%, as seen from data on page 2 of its Q2 earnings release (see table below).
That implies that Domino's is squeezing large amounts of cash out of its operations. As a result, we can project higher FCF for the company over the next 12 months (NTM).
Forecasting FCF
Analysts project 2025 sales will be $4.94 billion and $5.27 billion in 2026. That means its NTM sales forecast is $5.1 billion. So, applying the 14.7% FCF margin:
$5.1b x 0.147 = $750 million FCF
That is +22% higher than the trailing 12 months (TTM) FCF of $613.2 million, according to Stock Analysis.
In other words, DPZ stock could be significantly undervalued if this occurs. But how much?
Target Price Based on FCF
One way to value DPZ stock using this FCF forecast is to use a FCF yield metric. For example, DPZ's market cap today is $15.778 billion (based on 33.9489 million shares outstanding at $464.76).
That implies that its TTM FCF of $613.2 million represents 3.886% of its market value (i.e., a 3.9% FCF yield).
Therefore, we can apply that metric (assuming the same valuation lasts over the next 12 months) to our FCF forecast:
$750m NTM FCF / 0.039 = $19.231 billion mkt value
That is +21.88% higher than today's $15.778 billion market cap. In other words, DPZ could be worth 21.9% more over the next 12 months:
$464.76 x 1.2188 = $566.45 target price
There are other ways to value DPZ stock. One way is to use its historic dividend yield.
Target Price Using Dividend Yield
For example, right now, based on Domino's quarterly $1.74 dividend per share (DPS), its annual yield is 1.50%:
$1.74 x 4 = $6.96/$464.76 = 0.01497 = 1.50%
But historically, based on Morningstar's calculations, its average yield has been lower at 1.02% over the last 5 years. Yahoo! Finance says it's been 1.08%. So, using this higher average we can estimate where DPZ should trade if it reverts to this mean yield:
$6.96 DPS / 0.0108 = $644.44 target price
That provides an investor with a potential upside of +39% from today's price.
Another way to value the stock is to use analysts' target prices.
Target Price Using Analysts' Projections
Analysts surveyed by Barchart have a mean price target of $509.55, and Yahoo! Finance reports that 32 analysts have an average of $505.35.
Similarly, Stock Analysis reports that 23 analysts have a price average of $486.83, but AnaChart's survey of 26 analysts is $514.19.
So, the mean analyst survey price is $503.98, or +8.4% over today's price.
Summary of Price Targets
So, using these three valuation methods, we can estimate its price target at:
FCF Yield target ………. $566.45
Dividend Yield ………… $644.44
Analysts' targets …….. $503.98
Average Price Target … $571.62, or +22.9% higher than today
The bottom line here is that DPZ stock looks deeply undervalued. One way to play this is to set a lower buy-in price by shorting out-of-the-money (OTM) put options.
Shorting OTM Puts
For example, the August 15 expiration period shows that the $440.00 strike price put option, 4.8% below today's price, has a $3.75 premium. That provides a short seller an immediate yield of 0.852% (i.e., $3.75/$440.00).
Moreover, the 450.00 strike price put has a $6.10 premium. A short seller can make an immediate yield of 1.1356% (i.e., $6.10/$450.00).
As a result, using a 50/50 mix of these two strike prices, an investor could set a lower buy-in of $445 and make 1.111% on average ($4.925/$445) over the next 25 days.
That sets a buy-in that is about 4.3% below today's price and provides a good breakeven of just $440.07 per share (i.e., $445-$4.93). That is over 5.3% below today's price, so it provides good downside protection to investors.
Moreover, note that the delta ratio, i.e., the risk of this strike price being assigned based on historical variance, is low at between 20% and 30%.
The bottom line here is that DPZ stock looks deeply undervalued, and one way to set a good buy-in point is to short OTM puts.
On the date of publication, Mark R. Hake, CFA did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Option Care Health, Inc. (OPCH): A Bull Case Theory
Option Care Health, Inc. (OPCH): A Bull Case Theory

Yahoo

time25 minutes ago

  • Yahoo

Option Care Health, Inc. (OPCH): A Bull Case Theory

We came across a bullish thesis on Option Care Health, Inc. on Brian's Substack by Brian Flasker. In this article, we will summarize the bulls' thesis on OPCH. Option Care Health, Inc.'s share was trading at $29.35 as of July 31st. OPCH's trailing and forward P/E were 23.29 and 19.65, respectively according to Yahoo Finance. A home infusion nurse in full PPE gown delivering treatments to a patient in their own home. Option Care Health (OPCH) has evolved into the dominant independent provider of home and alternate site infusion services in the U.S., originating from Madison Dearborn Partners' 2015 acquisition of Walgreens Infusion Services. The 2019 reverse merger with BioScrip and full divestiture by Walgreens and MDP by 2023 paved the way for OPCH to operate with full independence. Led by CEO John Rademacher and CFO Michael Shapiro, both with substantial equity stakes, OPCH has built a national infrastructure of 91 pharmacies and 99 infusion suites, covering 96% of the U.S. population. The company's integrated model provides cost-effective, high-quality infusion therapies in outpatient and home settings, capitalizing on a healthcare trend shifting treatments away from costly hospitals. This platform serves over 1,400 contracts with 800+ partners, including all top 10 national insurers. Acute therapies, though operationally complex, act as a competitive wedge, while chronic therapies anchor long-term recurring revenues. OPCH's mix—75% chronic, 25% acute—combined with a focus on generics and biosimilars, ensures resilience against pricing volatility. With its Advanced Practitioner (AP) model, OPCH is pushing clinical boundaries, managing more complex therapies in lower-cost settings and enhancing utilization of its already-built infrastructure. Only ~50% of its infusion suite capacity is currently utilized, leaving ample runway for capital-light growth. Despite industry concerns like drug pricing reforms and labor shortages, OPCH's embedded relationships, clinical capabilities, and scalable model offer strong visibility into cash flow and earnings. Trading at ~15.4x 2025 owner earnings with a 17.4% expected IRR, OPCH represents a high-quality compounder with an entrenched moat and significant upside. Previously, we covered a bullish thesis on Chemed Corporation by 310 Value in April 2025, which highlighted the durability of its earnings, temporary volatility in its subsidiaries, and disciplined share repurchases. The company's stock price has depreciated by approximately 29% since our coverage. This is because temporary segment headwinds persisted longer than expected. The thesis still stands as Chemed's core fundamentals remain intact. Brian Flasker shares a similar view but emphasizes OPCH's capital-light model and payer-aligned infrastructure. Option Care Health, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held OPCH at the end of the first quarter, which was 40 in the previous quarter. While we acknowledge the potential of OPCH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Steel Dynamics, Inc. (STLD): A Bull Case Theory
Steel Dynamics, Inc. (STLD): A Bull Case Theory

Yahoo

time25 minutes ago

  • Yahoo

Steel Dynamics, Inc. (STLD): A Bull Case Theory

We came across a bullish thesis on Steel Dynamics, Inc. on Stock Picker's Journey's Substack by Gregg Jahnke. In this article, we will summarize the bulls' thesis on STLD. Steel Dynamics, Inc. 's share was trading at $127.56 as of July 31st. STLD's trailing and forward P/E were 18.51 and 14.29 respectively according to Yahoo Finance. Steel Dynamics (STLD) has been added to the Model 25 portfolio at $131, replacing AES, in a rare top-down decision driven by macroeconomic expectations rather than valuation. While the author typically favors bottom-up stock picks like Pepsi and Gentex, which were purchased at near-decade lows, the potential passage of the BBBill and a possible economic surge in 2026 prompted this more thematic move. STLD stands to benefit from pro-growth industrial policies, and with momentum shifting in favor of the bill's passage, exposure to a high-quality cyclical stock became desirable. A standout first-quarter earnings call reinforced conviction, as STLD's aggressive capital expenditure plans—particularly its efforts to reshape the aluminum industry—signal long-term vision. Notably, the company has repurchased 40% of its stock over the past decade and maintains a clean balance sheet, having recently refinanced debt with manageable near-term maturities. Although other aluminum plays like Century, Alcoa, and Kaiser were considered, STLD was viewed as superior, even compared to Nucor (NUE), due to its aluminum exposure. Wall Street's focus on short-term earnings has led to a misunderstanding of STLD's strategic positioning, as highlighted by analyst John Tumazos's incisive questioning on the Q1 call. The company's spread-based model in scrap steel and aluminum is seen as lower risk than perceived, with significant upside potential. Strong institutional support from Victory Capital, Norges Bank, and T. Rowe Price adds credibility to the investment. Though STLD has underperformed recently and issued a soft Q2 outlook, the long-term case for its role in rebuilding U.S. manufacturing justifies the timing of this buy. Previously, we covered a on Steel Dynamics, Inc. (STLD) by Gregg Jahnke in February 2025, which highlighted the company's capital discipline, low-cost structure, and long-term potential. The company's stock price has depreciated approximately by 4% since our coverage due to near-term macro headwinds. Gregg Jahnke shares a similar view but emphasizes a top-down, policy-driven case based on expected 2026 growth. Steel Dynamics, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held STLD at the end of the first quarter which was 45 in the previous quarter. While we acknowledge the potential of STLD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Snap-on Incorporated (SNA): A Bull Case Theory
Snap-on Incorporated (SNA): A Bull Case Theory

Yahoo

time25 minutes ago

  • Yahoo

Snap-on Incorporated (SNA): A Bull Case Theory

We came across a bullish thesis on Snap-on Incorporated on The Reservist's Substack by Yehoshua Zlotogorski. In this article, we will summarize the bulls' thesis on SNA. Snap-on Incorporated's share was trading at $321.19 as of July 31st. SNA's trailing and forward P/E were 17.11 and 17.24, respectively according to Yahoo Finance. An engineer at a workbench surrounded by automotive parts, tools, and microchips. Snap-On's latest earnings report reinforces the author's conviction in a trade built on a favorable risk/reward setup. The position, entered with a tight downside near $300 (a 3% loss), is based on Snap-On's strong fundamentals and dominant market position, which help anchor valuation. The key bullish thesis is that the post-pandemic lull in tool and equipment purchases—now entering its final stages- will fade by late 2025 into 2026, setting up for a cyclical rebound. This quarter supports that view: the Tools Group returned to growth (+1.7%) after four quarters of decline, RS&I also expanded, and while C&I fell 8%, the drop was attributed largely to temporary effects, with a recovery seen as the quarter progressed. Management continues to deflect with macro and geopolitical explanations, but the author sees the stagnation as a result of pandemic-era pull-forward, supported by weak financing data for big-ticket items. As these loans roll off over their typical four-year cycles, demand should return. The author also sees Snap-On as a likely beneficiary of tariff relief and potential industrial spending from the so-called 'Big Beautiful bill,' both of which could drive relative outperformance. Meanwhile, margins remain strong, cash builds, buybacks persist, and the 2.75% dividend provides a steady return while awaiting the upturn. The stock could rise 30% back to its historical $370–390 range, with minimal downside. Sized at 4% of the portfolio, the position provides lower beta industrial exposure while retaining the upside target common across the author's broader trading strategy. Further adds are possible on dips near $300. Previously, we covered a on Snap-on Incorporated (SNA) by William Fleming-Daniels in November 2024, which highlighted strong margins, stable cash flow, and long-term growth. The company's stock has depreciated ~11% since our coverage, as the thesis hasn't played out yet. Yehoshua Zlotogorski shares a similar view but emphasizes a near-term cyclical rebound driven by financing roll-offs. Snap-on Incorporated is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 36 hedge fund portfolios held SNA at the end of the first quarter which was 32 in the previous quarter. While we acknowledge the potential of SNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store